Melanocortin medicine
Bremelanotide
PT-141
Bremelanotide is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->Transparent peptide, NAD+ and longevity compound database
Peptides, NAD+ and longevity compounds
research, evidence and testing in one place.
Peptide Record organizes compounds, tracks what research has actually found, and reviews the laboratory testing and supplier documents available behind commercial products.
Research summaries · evidence strength · safety and unknowns · lab-test results · certificates of analysis (COAs) · clearly labelled commercial links
Bremelanotide·Semaglutide·Tesamorelin·Tirzepatide·Creatine·Elamipretide·Metformin·Nicotinamide riboside·NMN·Rapamycin·Retatrutide·Acarbose·Berberine·GHK-Cu·Glycine·Quercetin·Resveratrol·Sermorelin·Spermidine·Taurine·Thymosin alpha-1·Urolithin A·Alpha-ketoglutarate·BPC-157·CJC-1295·Epitalon·Fisetin·Humanin·Ipamorelin·KPV·LL-37·Melanotan II·MOTS-c·NAD+·Selank·Semax·TB-500·AOD-9604·Cycloastragenol·DSIP·Bremelanotide·Semaglutide·Tesamorelin·Tirzepatide·Creatine·Elamipretide·Metformin·Nicotinamide riboside·NMN·Rapamycin·Retatrutide·Acarbose·Berberine·GHK-Cu·Glycine·Quercetin·Resveratrol·Sermorelin·Spermidine·Taurine·Thymosin alpha-1·Urolithin A·Alpha-ketoglutarate·BPC-157·CJC-1295·Epitalon·Fisetin·Humanin·Ipamorelin·KPV·LL-37·Melanotan II·MOTS-c·NAD+·Selank·Semax·TB-500·AOD-9604·Cycloastragenol·DSIP·
Start here
What compound are you researching?
Search by compound name, accepted abbreviation or research topic.
Popular:
Compound database
Explore popular compounds
Start with commonly researched peptides, NAD+ compounds and metabolic medicines, or open the complete repository.
Semaglutide
GLP-1 receptor agonist
A GLP-1 receptor agonist with controlled clinical evidence for specific approved uses, where product status, jurisdiction, and formulation matter.
View compound record ->
GHRH analog medicine
Tesamorelin
Tesamorelin
Tesamorelin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Tirzepatide
Zepbound
A dual GIP/GLP-1 receptor agonist with strong clinical evidence in approved-product contexts and separate questions for compounded products.
View compound record ->
Energy metabolism compound
Creatine
Creatine monohydrate
Creatine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Mitochondrial peptide
Elamipretide
SS-31
Elamipretide is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Metformin
Glucophage
Metformin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
NAD+ precursor
Nicotinamide riboside
Nicotinamide riboside
Nicotinamide riboside is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
View compound record ->
NAD+ precursor
NMN
Nicotinamide mononucleotide
A NAD+ precursor studied in metabolism and aging-biology contexts, with stronger human relevance than many research peptides but still outcome-specific evidence.
View compound record ->
mTOR inhibitor medicine
Rapamycin
Sirolimus
Rapamycin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->Triple incretin agonistRetatrutideTriple incretin agonist
Retatrutide
LY3437943
An investigational triple GLP-1/GIP/glucagon receptor agonist with strong phase 2 signals but no approved-product status yet.
View compound record ->
Alpha-glucosidase inhibitor
Acarbose
Precose
Acarbose is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Plant alkaloid
Berberine
Berberine
Berberine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Copper peptide
GHK-Cu
GHK copper
A copper-binding tripeptide often discussed in skin, wound-context, and cosmetic research, with evidence varying sharply by formulation and outcome.
View compound record ->
Amino acid
Glycine
Glycine
Glycine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Polyphenol compound
Quercetin
Quercetin
Quercetin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Polyphenol compound
Resveratrol
Resveratrol
Resveratrol is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
GHRH peptide
Sermorelin
Sermorelin
Sermorelin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Polyamine compound
Spermidine
Spermidine
Spermidine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Amino sulfonic acid
Taurine
Taurine
Taurine is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Immune peptide
Thymosin alpha-1
Thymalfasin
Thymosin alpha-1 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Mitophagy compound
Urolithin A
Urolithin-A
Urolithin A is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
TCA-cycle metabolite
Alpha-ketoglutarate
AKG
Alpha-ketoglutarate is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Peptide
BPC-157
BPC 157
A synthetic peptide discussed for tissue repair and gastrointestinal models, with most public claims still relying on preclinical research.
View compound record ->
GHRH analog peptide
CJC-1295
CJC-1295
CJC-1295 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Longevity peptide
Epitalon
Epitalon
Epitalon is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
View compound record ->
Flavonoid senolytic candidate
Fisetin
Fisetin
Fisetin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Mitochondrial peptide
Humanin
Humanin
Humanin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Ghrelin receptor peptide
Ipamorelin
Ipamorelin
Ipamorelin is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Anti-inflammatory tripeptide
KPV
KPV
KPV is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
View compound record ->
Antimicrobial peptide
LL-37
Cathelicidin LL-37
LL-37 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Melanocortin peptide
Melanotan II
Melanotan II
Melanotan II is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
View compound record ->
Mitochondrial peptide
MOTS-c
MOTS-c
MOTS-c is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
View compound record ->
NAD+ coenzyme
NAD+
NAD+
NAD+ is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
View compound record ->
Neuropeptide analog
Selank
Selank
Selank is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Neuropeptide analog
Semax
Semax
Semax is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
View compound record ->
Peptide
TB-500
Thymosin beta-4 fragment
A peptide commonly associated with thymosin beta-4 discussions and recovery claims, where evidence must be separated by exact molecule and model.
View compound record ->
GH fragment peptide
AOD-9604
AOD9604
AOD-9604 is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Telomerase-associated compound
Cycloastragenol
Cycloastragenol
Cycloastragenol is tracked as part of the peptide, metabolic, mitochondrial, NAD, or longevity research landscape, with claims separated by evidence type and product documentation.
View compound record ->
Sleep peptide
DSIP
DSIP
DSIP is tracked because it appears in peptide, NAD, metabolic, or longevity discussions and needs claim-by-claim evidence review.
View compound record ->No homepage compound matches that search. Open the complete repository for more records.
Explore by research purpose
Start with the question not the compound.
Use these pages when you know the topic you are researching but not which compounds appear in the evidence.
01
Recovery & tissue repair
Healing processes, inflammation, connective tissue and recovery, with preclinical and human findings kept separate.
BPC-157 · TB-500 · GHK-Cu 02NAD+ & cellular metabolism
NAD biology, energy pathways, metabolic markers and whether biomarker changes translate into meaningful outcomes.
NMN · NR · NAD+ 03Skin, hair & appearance
Topical, cosmetic and systemic research involving collagen biology, pigmentation, hair growth and visible outcomes.
GHK-Cu · Melanotan II · topical peptides 04Appetite & weight regulation
Approved medicines and investigational compounds separated by ingredient, formulation and clinical status.
Semaglutide · Tirzepatide · Retatrutide 05Sleep & circadian biology
Compounds and pathways studied in relation to sleep timing, architecture, recovery and circadian signalling.
Epitalon · DSIP · melatonin pathways 06Healthy-aging research
Senescence, mitochondrial biology, metabolic health and age-related biomarkers, without treating biomarkers as proof of longer life.
NAD+ precursors · senolytics · mitochondrial targetsInside every compound record
Everything important, in one place.
Each section answers a different question, so biological rationale, clinical evidence, safety information and supplier documents never blend into one score.
Overview & mechanism
Identity, accepted names, molecular class and proposed biological pathways.
Proposed effects
Claims grouped by the specific outcome researchers actually measured.
Evidence map
Mechanistic, cell, animal, observational and controlled-human evidence shown separately.
Studies & findings
Population, methods, outcomes, results and limitations for each study.
Safety & unknowns
Known safety information beside the gaps that current research cannot answer.
Potential adverse effects
Observed events, plausible risks, contraindications and uncertainty by confidence level.
Testing, COAs & suppliers
Available identity, purity and batch documents, plus what remains unverified.
Maintained records
Recently updated
Important changes appear on the relevant record with an exact date and a clear description of what changed.
Study addedNMN
New human study added to the metabolism and biomarker evidence map.
View update -> Safety reviewBPC-157Safety section revised to distinguish reported findings from major evidence gaps.
View update -> Trial outcomeSemaglutideStudy record updated with outcome definitions and longer-term follow-up context.
View update ->Laboratory documentation
See what a COA actually proves.
A purity percentage, identity result or certificate of analysis can provide useful information, but none independently proves that a product is safe, sterile, correctly handled or clinically effective.
Learn how to read a COAIdentity
Whether the tested material appears consistent with the stated compound.
Purity
What proportion of detected material appears to be the intended target under the stated method.
Missing questions
Sterility, endotoxins, contaminants, chain of custody, batch matching and laboratory independence.
Editorial standard
Evidence and commercial information stay separate.
Evidence by type. Mechanistic, animal, observational and controlled-human findings are never treated as equivalent.
Limitations remain visible. Missing data, small samples, indirect outcomes and uncertainty stay beside the findings.
Commercial links are labelled. Affiliate relationships do not determine evidence summaries or documentation scores.
Records are dated. Every material update, correction and supplier-document check has a visible review date.
Read our editorial standards ->Frequently asked
Good questions before you continue.
Does Peptide Record provide medical or dosing advice?
No. The platform explains compounds, research, evidence limits, safety information and available documentation. It does not recommend treatment, dosing or purchasing decisions.
Does a COA prove that a product is safe?
No. A COA can document selected test results for a particular sample or batch. Its value depends on the methods, laboratory, chain of custody, batch matching and what was not tested.
How do you compare evidence between compounds?
We do not give every compound one universal score. Evidence is mapped by claim, outcome, study type, population and current level of uncertainty.
How are affiliate links handled?
Commercial links are clearly labelled and separated from research summaries, evidence interpretation and supplier-document reviews.
Peptide Record